130 related articles for article (PubMed ID: 22875707)
1. Conditional survival of high-grade glioma in Los Angeles County during the year 1990-2000.
Tsao-Wei DD; Hu J; Groshen SG; Chamberlain MC
J Neurooncol; 2012 Oct; 110(1):145-52. PubMed ID: 22875707
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
3. Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma.
DeLorenze GN; McCoy L; Tsai AL; Quesenberry CP; Rice T; Il'yasova D; Wrensch M
BMC Cancer; 2010 May; 10():215. PubMed ID: 20482871
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
5. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.
Yang W; Xu T; Garzon-Muvdi T; Jiang C; Huang J; Chaichana KL
World Neurosurg; 2018 Mar; 111():e323-e334. PubMed ID: 29258929
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
7. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
9. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
10. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection.
Wu J; Kim C; Bai HX; Tang L; Wang Y; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Xiao B; Yang L
World Neurosurg; 2019 Feb; 122():e108-e120. PubMed ID: 30261385
[TBL] [Abstract][Full Text] [Related]
12. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.
Davis FG; McCarthy BJ; Freels S; Kupelian V; Bondy ML
Cancer; 1999 Jan; 85(2):485-91. PubMed ID: 10023719
[TBL] [Abstract][Full Text] [Related]
13. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.
Claus EB; Black PM
Cancer; 2006 Mar; 106(6):1358-63. PubMed ID: 16470608
[TBL] [Abstract][Full Text] [Related]
14. Conditional survival of all primary brain tumor patients by age, behavior, and histology.
Porter KR; McCarthy BJ; Berbaum ML; Davis FG
Neuroepidemiology; 2011; 36(4):230-9. PubMed ID: 21677447
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
16. Prediction of pathology and survival by FDG PET in gliomas.
Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database.
Qaddoumi I; Sultan I; Gajjar A
Cancer; 2009 Dec; 115(24):5761-70. PubMed ID: 19813274
[TBL] [Abstract][Full Text] [Related]
18. Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.
Song K; Lin K; Guan H; Li F
Spine (Phila Pa 1976); 2020 Aug; 45(16):1110-1117. PubMed ID: 32205690
[TBL] [Abstract][Full Text] [Related]
19. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
20. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
